1. Introduction {#sec1}
===============

Psoriasis is an immunologically mediated chronic inflammatory and hyperproliferative skin disease affected by both genetic and environmental factors. The prevalence of psoriasis varied among populations with different genetic backgrounds and habitats, from 3% in Northern Europe and 2% in North America and the UK to 0.1--0.3% in American Indians and East Asia \[[@B1], [@B2]\]. Psoriasis is proposed to be associated with other immune diseases, such as arthritis and Crohn\'s disease \[[@B3]\]. Initial causative research has identified strong association between psoriasis and the interleukin genes (IL4, IL10, IL12B, IL13, and IL23R) in the northern European from US and UK \[[@B4]--[@B7]\]. Furthermore, the SNP rs56245420 in the IL15 gene has been found to be associated with psoriasis in the Chinese Han population but not in any of the UK, German, or US Caucasian populations investigated \[[@B8]--[@B10]\], since the minor allele frequency for this SNP and others across IL15 differs quite strikingly between the populations, suggesting heterogeneity in the genetic susceptibility to psoriasis.

In this study, we aimed to determine if psoriasis is associated with six IL genes that have been strongly associated with psoriasis in Europeans but not well studied in Chinese. The seven included SNPs are rs2243250 in the IL4 gene, rs1800872 in the IL10 gene, rs3212227 in the IL12B gene, rs1800925 and rs20541 in the IL13 gene, rs56245420 in the IL15 gene, and rs11209026 in the IL23R gene.

2. Materials and Methods {#sec2}
========================

2.1. Study Population {#sec2.1}
---------------------

A total of 200 psoriasis patients and 298 healthy controls were recruited in this study (see [Table 2](#tab2){ref-type="table"}). All participants did not suffer from any other diseases and belonged to Han nationality in Yunnan Province, China. The study was performed according to the Helsinki Declaration with approval of the institutional review boards of the Affiliated Yan\'an Hospital of Kunming Medical College and the Kunming Institute of Botany. Informed consent was obtained from each participant before inclusion in this study.

2.2. Determination of Genotype {#sec2.2}
------------------------------

Genomic DNAs were isolated from whole blood using regular phenol/chloroform method. The SNP rs11209026 in the IL23R gene was genotyped by the TaqMan allelic discrimination method (Applied Biosystems). New PCR-RFLP methods were generated to genotype the SNP rs56245420 in the IL15 gene. Primers 5′-TTT CTG TTA TTA ACA AAC ATC ACT CTG-3′ and 5′-CAA CAC TTG TAC ATA TTT TTA TTC**AAt AT**-3′ (mismatch is shown in bold lower case) were used for rs56245420. Other five SNPs were genotyped by PCR-RFLP methods described previously with slight modification \[[@B11]--[@B15]\]. PCR reaction was carried out in a total volume of 20 *μ*L containing 20 ng of genomic DNA, 1 × PCR buffer, 1.5 mM MgCl~2~, 200 *μ*M of each dNTP, 30 ng of each primer, and 1 unit of Taq DNA polymerase (TakaRa). Samples were denatured at 95°C for 2 min followed by 30 cycles of 94°C for 45 sec, 61°C (rs2395029) or 54°C (rs56245420) for 45 sec, and 72°C for 45 sec and ended with a final extension for 7 min at 72°C. PCR products were digested with 4 U of appropriate restriction endonuclease and electrophoresed on 3% agarose gels and stained with ethidium bromide. The restriction endonucleases, PCR product lengths, and restriction patterns are shown in [Table 1](#tab1){ref-type="table"}.

2.3. Data Analysis {#sec2.3}
------------------

Statistics analysis was performed by SPSS software for windows (SPSS Inc.). The frequencies of genotypes and alleles for all the six studied loci were determined assuming codominant inheritance. The Hardy-Weinberg equilibrium (HWE) for six loci in psoriasis patients and controls was tested by means of chi-square tests. The statistical significance of the genotype and allele frequency variables between the psoriasis patients and control group was evaluated by chi-square test with Yates correction for small numbers. Relative risk associated with the significant genotype was estimated by the odds ratio (OR). OR with 95% confidence intervals (95% CI) was tested using a chi-square distribution and the null hypothesis being tested is OR = 1. *P* values \<0.05 were considered as statistically significant.

3. Results {#sec3}
==========

Only one of the fourteen Hardy-Weinberg tests (seven polymorphic loci each in the psoriasis patient and control groups) had *P* values smaller than 0.05 (*P* = 0.01 at rs3212227 in controls). All nine remaining genotype frequencies fit Hardy-Weinberg expectations according to chi-square tests in psoriasis patients and controls (*P* \> 0.05). Therefore, there is no meaningful deviation from WHE, and our population is derived from random mating.

Polymorphism (minor allele frequency \> 1%) has been found for all studied SNPs except for rs11209026 in the IL23R gene ([Table 2](#tab2){ref-type="table"}). [Table 2](#tab2){ref-type="table"} shows that rs3212227 in the IL12B gene (*P* = 0.0218) was associated with psoriasis at genotypic level in the studied population. Other SNPs examined were not associated with psoriasis considered from single locus. As shown in [Table 3](#tab3){ref-type="table"}, while the A/C genotype (OR = 1.48; 95% CI: 0.95--2.30) and the alleles (OR = 0.84; 95% CI: 0.63--1.13) at rs3212227 in the IL12B were not a risk factor of psoriasis, the C/C genotype was a protective factor of psoriasis (OR = 0.51; 95% CI: 0.27--0.96).

4. Discussion {#sec4}
=============

The etiology of psoriasis is a complex interaction of environmental and biological factors. Genetic factors may play a significant role in the risk of psoriasis in Chinese \[[@B10], [@B16]\]. Recent genetic studies indicate that the location of these genes varies considerably among populations and families. We are interested to know if psoriasis is associated with the genes that have been strongly associated with psoriasis in Europeans but not well studied in Chinese.

Our results showed that the IL12B gene was associated with psoriasis in Chinese at genotypic level (*P* \< 0.05), which is in line with the findings from European studies \[[@B17]\]. The C/C genotype for rs3212227 in IL12B is a protective factor (OR = 0.51) from psoriasis. Similar result from studying SNP rs6887695 in IL12B showed that the minor allele C was a protective factor from psoriasis \[[@B5]\].

The nonsynonymous SNP in IL23R, rs11209026, widely thought to be the primary psoriasis-associated SNP in IL23R in Europeans, was found not to be polymorphic in Chinese, which is in agreement with the findings of others \[[@B18]\]. The low frequencies of variant in IL23R are accordingly of low risk for psoriasis in Chinese. With single SNP analysis, no association is found between the psoriasis and the IL4, IL10, IL13, and IL15 genes.
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###### 

Primer sequences, PCR product lengths, restriction endonucleases, and restriction patterns for the PCR-RFLP analyzed SNPs.

  SNP          Gene    Position of SNP in genomic sequence   Forward primer^a^                 Reverse primer                             Anneal temperature (°C)   Product length (bp)   Restriction endonucleases   Fragments of frequent allele genotype (bp)   Fragments of heterozygous genotype (bp)   Fragments of rare allele genotype (bp)   Reference
  ------------ ------- ------------------------------------- --------------------------------- ------------------------------------------ ------------------------- --------------------- --------------------------- -------------------------------------------- ----------------------------------------- ---------------------------------------- ------------
  rs2243250    IL4     132009154:C/T                         TAAACTTGGGAGAACAT**[G]{.ul}**GT   TGGGGAAAGATAGAGTAATA                       49                        195                   AvaII                       195                                          22 + 173 + 195                            22 + 173                                 \[[@B1]\]
  rs1800872    IL10    206946407:A/C                         AGGTGATGTAATATCTCTGT              TAAATATCCTCAAAGTTCC                        57                        303                   RsaI                        65 + 238                                     65 + 238 + 303                            303                                      \[[@B2]\]
  rs3212227    IL12B   158742950:A/C                         TTCTATCTGATTTGCTTTA               TGAAACATTCCATACATCC                        51                        233                   TaqI                        233                                          68 + 165 + 233                            68 + 165                                 \[[@B3]\]
  rs1800925    IL13    131992809:C/T                         GTCGCCTTTTCCTGCTCTTCCCGC          GGAATCCAGCATGCCTTGTGAGG                    65                        247                   Bsh1236I                    23 + 224                                     23 + 224 + 247                            247                                      \[[@B4]\]
  rs20541      IL13    131995964:C/T                         TAGGCTGAAGACGGGCAGCA              AAGAAACTTTTTCGCGAGGG**[C]{.ul}**C          63                        199                   MspI                        22 + 177                                     22 + 177 + 199                            199                                      \[[@B5]\]
  rs56245420   IL15    142873720:A/T                         TTTCTGTTATTAACAAACATCACTCTG       CAACACTTGTACATATTTTTATTCAA**[T]{.ul}**AT   54                        274                   SspI                        27 + 247                                     27 + 247 + 274                            274                                      This study

^a^Mismatch is shown in bold and underlined font.

###### 

Genotyping of seven studied SNPs in psoriasis patients (*n* = 200) and controls (*n* = 298).

  SNP          Gene         Population   Genotype (%)   Minor allele (%)         
  ------------ ------------ ------------ -------------- ------------------ ----- ---
  rs2243250    IL4                       T/T            T/C                C/C   C
  Controls     189 (63.4)   98 (32.9)    11 (3.7)       120 (20.1)               
  Psoriasis    127 (63.5)   61 (30.5)    12 (6.0)       85 (21.3)                
                                                                                 
  rs1800872    IL10                      A/A            A/C                C/C   C
  Controls     138 (46.3)   123 (41.3)   37 (12.4)      197 (33.1)               
  Psoriasis    93 (46.5)    86 (43.0)    21 (10.5)      128 (32.0)               
                                                                                 
  rs3212227    IL12B                     A/A            A/C                C/C   C
  Controls     119 (39.9)   128 (43.0)   51 (17.1)      230 (38.6)               
  Psoriasis    77 (38.5)    104 (52.0)   19 (9.5)^∗a^   142 (35.5)               
                                                                                 
  rs1800925    IL13                      C/C            C/T                T/T   T
  Controls     222 (74.5)   72 (24.2)    4 (1.3)        80 (13.4)                
  Psoriasis    140 (70.0)   52 (26.0)    8 (4.0)        68 (17.0)                
                                                                                 
  rs20541      IL13                      C/C            C/T                T/T   T
  Controls     146 (49.0)   126 (42.3)   26 (8.7)       178 (29.9)               
  Psoriasis    100 (50.0)   80 (40.0)    20 (10.0)      120 (30.0)               
                                                                                 
  rs56245420   IL15                      A/A            A/T                T/T   T
  Controls     139 (46.6)   135 (45.3)   24 (8.1)       183 (30.7)               
  Psoriasis    78 (39.0)    97 (48.5)    25 (12.5)      147 (36.8)               
                                                                                 
  rs11209026   IL23R                     G/G            G/A                A/A   A
  Controls     298 (100)    0            0              0                        
  Psoriasis    200 (100)    0            0              0                        

^∗a^ *P* = 0.0218.

###### 

Correlation of psoriasis symptoms with SNPs in the IL genes.

  SNP          Genotype   Psoriasis   Controls             OR (95% CI)   Allele   Psoriasis   Controls            OR (95% CI)
  ------------ ---------- ----------- -------------------- ------------- -------- ----------- ------------------- -------------
  rs2243250    TT         127         189                                T        315         476                  
  TC           61         98          0.93 (0.63--1.37)    C             85       120         1.07 (0.78--1.46)   
  CC           12         11          1.62 (0.69--3.78)                                                           
  TC-CC        73         109         1.00 (0.69--1.45)                                                           
                                                                                                                  
  rs1800872    AA         93          138                                A        272         399                  
  AC           86         123         1.04 (0.71--1.52)    C             128      197         0.95 (0.72--1.25)   
  CC           21         37          0.84 (0.46--1.53)                                                           
  AC-CC        107        160         0.99 (0.69--1.42)                                                           
                                                                                                                  
  rs3212227    CC         19          51                                 C        142         230                  
  AC           104        128         2.18 (1.21--3.92)    A             258      366         1.14 (0.88--1.48)   
  AA           77         119         1.71 (0.96--3.17)                                                           
  AC-AA        181        247         1.97 (1.12--3.45)                                                           
                                                                                                                  
  rs1800925    CC         140         222                                C        332         516                  
  CT           52         72          1.15 (0.76--1.74)    T             68       80          1.32 (0.93--1.86)   
  TT           8          4           3.17 (0.94--10.72)                                                          
  CT-CC        60         76          1.25 (0.84--1.86)                                                           
                                                                                                                  
  rs20541      CC         100         146                                C        280         418                  
  CT           80         126         0.93 (0.64--1.36)    T             120      178         1.01 (0.77--1.33)   
  TT           20         26          1.12 (0.59--2.12)                                                           
  CT-TT        100        152         0.96 (0.67--1.37)                                                           
                                                                                                                  
  rs56245420   AA         78          139                                A        253         413                  
  AT           97         135         1.28 (0.87--1.87)    T             147      183         1.28 (1.00--1.71)   
  TT           25         24          1.85 (0.99--3.46)                                                           
  AT-TT        122        159         1.36 (0.94--1.96)                                                           
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